Status:

UNKNOWN

Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.

Lead Sponsor:

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Collaborating Sponsors:

University Hospital, Ghent

University of Liege

Conditions:

Severe Asthma

Eligibility:

All Genders

18-80 years

Phase:

PHASE4

Brief Summary

Pragmatic trial to define the magnitude and the predictive factors of the response to omalizumab and mepolizumab in adult patients with severe refractory asthma and eligible to both therapies.

Detailed Description

Title "PREDICTUMAB: Predictive factors and magnitude of response to omalizumab and mepolizumab in allergic and eosinophilic severe asthma: a multicenter, open, active-controlled, randomized trial in a...

Eligibility Criteria

Inclusion

  • • Signed informed consent form (ICF),
  • Age \>18+ years at time of signing ICF,
  • Able to comply with the study protocol, in the investigator's judgment,
  • Documented physician-diagnosed asthma ,
  • Patients with severe disease and eligible to omalizumab and mepolizumab, and who have not yet received any of these therapies.

Exclusion

  • History of evidence of drug/substance abuse that would pose a risk to patient safety, interfere with the conduct of study, have an impact on the study results, or affect the patient's ability to participate in the study, in the opinion of the investigator
  • Treatment with any investigational therapy within 6 months or 5 drug half-lives prior to enrolment.
  • Known sensitivity to any of the active substances or their excipients to be administered during the study.

Key Trial Info

Start Date :

May 10 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2024

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT03476109

Start Date

May 10 2019

End Date

December 31 2024

Last Update

October 27 2022

Active Locations (13)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (13 locations)

1

Universitair Ziekenhuis Brussel

Brussels, Brussels Capital, Belgium, 1090

2

CHU de Charleroi

Charleroi, Hainaut, Belgium, 6000

3

Grand Hôpital de Charleroi

Charleroi, Hainaut, Belgium, 6000

4

Katholieke Universiteit Leuven

Leuven, Vlaams Brabant, Belgium, 3000